Legal Issues
Merck wins a causation claim, enters next phase in second case in New Jersey Vioxx case
Published in Cardiovascular Device Liability Week, May 7th, 2006
The jury also awarded a compensatory award to a second plaintiff. The trial is continuing into the punitive phase for the second plaintiff. Merck will present evidence it believes shows that the company submitted to the U.S. Food & Drug Administration all relevant and material information concerning Vioxx. Merck will make further statements after the jury completes its deliberations after this phase of the trial.
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Journal of American Medical Association Archives
ACE inhibitors may reduce death, heart attack and stroke in patients with coronary artery disease - Legal Issues
New Jersey appellate court upholds nationwide Vioxx-related class action against Merck - Massachusetts General Hospital
16-slice multi-detector CT permits accurate quantification of coronary artery stenosis - Massachusetts General Hospital
64-slice MDCT permits visualization of coronary arteries with minimal motion artifacts - Mount Sinai School of Medicine, New York
Acute decompensated heart failure is considered in first of 2-part review - Society for Experimental Biology
Brittlestar provides new model for stem cell research - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
